CORESTA Congress, 13-17 October 2024, Edinburgh, Scotland – UK
ALEXIS in collaboration with Alveolix and Vitrocell
Objective
The goal of this study is to evaluate the Health risks of traditional and alternative tobacco products using the smoke inhalation system. By simulating both acute and chronic exposure, we aim to assess how different product formulations affect lung cells. Specifically, we seek to observe cytotoxicity and inflammatory responses, providing valuable data to support safer product development and regulatory decisions.
